Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Baigent

Showing results (11-20 of 171) with videos related to

Pageof 18
Sort By:
Lancet (London, England)|August 1, 2021
What is the association of COVID-19 with heart attacks and strokes?Marion Mafham, Colin Baigent
Arthritis and Rheumatism|January 16, 2003
Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisalColin Baigent, Carlo Patrono
Kidney International. Supplement|April 16, 2003
Study of Heart and Renal Protection (SHARP)Colin Baigent, Martin Landry
Circulation|February 26, 2014
Nonsteroidal anti-inflammatory drugs and the heartCarlo Patrono, Colin Baigent
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2006
Which cardiovascular risk factors matter in chronic kidney disease?Colin Baigent, Martin Landray
Nature Reviews. Nephrology|July 4, 2017
Cardiovascular disease: PCSK9 inhibition: a new player in cholesterol-lowering therapies?David Preiss, Colin Baigent
Molecular Interventions|March 21, 2009
Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emergesCarlo Patrono, Colin Baigent
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 26, 2023
Revascularization of low-surgical risk patients with disease of the left main coronary artery: a fresh look at the evidenceColin Baigent, Rafael Sádaba
Current Opinion in Lipidology|July 13, 2006
Statins: are any questions unanswered?Patricia M Kearney, Colin Baigent
Nature Reviews. Cardiology|February 29, 2012
Prevention. Aspirin in primary prevention--good news and bad newsCharles H Hennekens, Colin Baigent
Pageof 18

Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
Lancet (London, England)|August 1, 2021
What is the association of COVID-19 with heart attacks and strokes?Marion Mafham, Colin Baigent
Arthritis and Rheumatism|January 16, 2003
Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisalColin Baigent, Carlo Patrono
Kidney International. Supplement|April 16, 2003
Study of Heart and Renal Protection (SHARP)Colin Baigent, Martin Landry
Circulation|February 26, 2014
Nonsteroidal anti-inflammatory drugs and the heartCarlo Patrono, Colin Baigent
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2006
Which cardiovascular risk factors matter in chronic kidney disease?Colin Baigent, Martin Landray
Nature Reviews. Nephrology|July 4, 2017
Cardiovascular disease: PCSK9 inhibition: a new player in cholesterol-lowering therapies?David Preiss, Colin Baigent
Molecular Interventions|March 21, 2009
Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emergesCarlo Patrono, Colin Baigent
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 26, 2023
Revascularization of low-surgical risk patients with disease of the left main coronary artery: a fresh look at the evidenceColin Baigent, Rafael Sádaba
Current Opinion in Lipidology|July 13, 2006
Statins: are any questions unanswered?Patricia M Kearney, Colin Baigent
Nature Reviews. Cardiology|February 29, 2012
Prevention. Aspirin in primary prevention--good news and bad newsCharles H Hennekens, Colin Baigent
Pageof 18